A GROUNDBREAKING cancer vaccine could stop tumours growing in patients with advanced disease, researchers say. Designed to ...

A wide selection of therapies are available to treat advanced prostate cancer, but the optimal treatment strategy is unknown.

Prostate cancer affects about 1 in 8 men in the United States. Highly treatable when caught early, regular screenings for ...

September is Prostate Cancer Awareness Month. According to the Prostate Cancer Foundation, in the U.S., 1 in 8 men will be ...

Bristol Myers Squibb, AstraZeneca, Eli Lilly and other drug companies have invested some $10 billion on promising cancer ...

Annexuzlimab is under clinical development by MedAnnex and currently in Phase I for Prostate Cancer. According to GlobalData, Phase I drugs for Prostate Cancer have a 76% phase transition success rate ...

Back in 2022, Nature published an article titled Cancer vaccines: the immunotherapy frontier, it signaled that after several decades of development that cancer vaccines were finally showing signs of ...

ESMO Congress, an expert explained how Nubeqa may reduce fatigue-related side effects in metastatic hormone-sensitive ...

By Stephen Strup UK Healthcare Prostate cancer is one of the most common cancers affecting men and the second-leading cause of cancer-related deaths among men in the U.S. While early detection can ...

Prostate cancer consultations are common in primary care and there is no one approach to testing and treatment that fits all ...

KETV NewsWatch 7 discussed the signs and prevention with Dr. Joan Delto, a urologist and associate professor with CHI Health ...

Get Healthy. Prostate cancer is the most common cancer among men in the United States, with an estimated 1 in 8 men being ...